{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:22:11Z","timestamp":1789766531668,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Key Science and Technology Project of Tianjin City","award":["13ZCZDSY02200"],"award-info":[{"award-number":["13ZCZDSY02200"]}]},{"name":"Peking Union of Medical College","award":["2011zlgc0110"],"award-info":[{"award-number":["2011zlgc0110"]}]},{"name":"Ministry of Science & Technology of China","award":["2011AA020115"],"award-info":[{"award-number":["2011AA020115"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jcyt.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T06:32:35Z","timestamp":1400135555000},"page":"1110-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia"],"prefix":"10.1016","volume":"16","author":[{"given":"Lingjie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2014.03.007_bib1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.03.007_bib2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.97.12.1108","article-title":"Therapeutic angiogenesis in ischemic limbs","volume":"97","author":"Folkman","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2014.03.007_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2009.07.050","article-title":"Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells","volume":"208","author":"Horie","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcyt.2014.03.007_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.03.007_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcyt.2014.03.007_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH03-06-0343","article-title":"Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities","volume":"91","author":"Huang","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcyt.2014.03.007_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH07-02-0137","article-title":"Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans","volume":"98","author":"Huang","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcyt.2014.03.007_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.vph.2012.02.010","article-title":"Development of pluripotent stem cells for vascular therapy","volume":"56","author":"Volz","year":"2012","journal-title":"Vasc Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2014.03.007_bib9","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.thromres.2012.08.287","article-title":"Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases","volume":"130","author":"Silvestre","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jcyt.2014.03.007_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ahj.2008.06.025","article-title":"Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia","volume":"156","author":"Matoba","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcyt.2014.03.007_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jcyt.2014.03.007_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.5966\/sctm.2012-0021","article-title":"A\u00a0phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study","volume":"1","author":"Schiavetta","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2014.03.007_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dmrr.2399","article-title":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment","volume":"29","author":"Dubsky","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcyt.2014.03.007_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcyt.2014.03.007_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1479-5876-11-143","article-title":"A\u00a0double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2014.03.007_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2482-13-S1-A1","article-title":"Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis","volume":"12","author":"Amato","year":"2012","journal-title":"BMC Surg"},{"key":"10.1016\/j.jcyt.2014.03.007_bib17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00392-007-0569-x","article-title":"Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study)","volume":"96","author":"Bartsch","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jcyt.2014.03.007_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jvs.2006.06.023","article-title":"Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans","volume":"44","author":"Durdu","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcyt.2014.03.007_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.gene.2013.03.097","article-title":"Therapeutic angiogenesis for revascularization in peripheral artery disease","volume":"525","author":"Grochot-Przeczek","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.jcyt.2014.03.007_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.03.007_bib21","doi-asserted-by":"crossref","first-page":"H1362","DOI":"10.1152\/ajpheart.00766.2005","article-title":"Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats","volume":"290","author":"Li","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcyt.2014.03.007_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.37757\/MR2012V14.N3.6","article-title":"Possible predictors of poor angiogenesis after hematopoietic stem cell autograft for lower limb ischemia","volume":"14","author":"Gomez","year":"2012","journal-title":"MEDICC Rev"},{"key":"10.1016\/j.jcyt.2014.03.007_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/CH-2012-1574","article-title":"Fibrinogen interaction with the red blood cell membrane","volume":"53","author":"Saldanha","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jcyt.2014.03.007_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.03.007_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease: the Framingham Study","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2014.03.007_bib26","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2014.03.007_bib27","doi-asserted-by":"crossref","first-page":"e62080","DOI":"10.1371\/journal.pone.0062080","article-title":"Circulating biomarkers for predicting cardiovascular disease risk: a systematic review and comprehensive overview of meta-analyses","volume":"8","author":"van Holten","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jcyt.2014.03.007_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.106.653501","article-title":"Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery","volume":"116","author":"Kulier","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2014.03.007_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jcyt.2014.03.007_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2125.2009.03486.x","article-title":"Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells","volume":"68","author":"Tilling","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcyt.2014.03.007_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cns.12040","article-title":"Endothelial progenitor cells: therapeutic perspective for ischemic stroke","volume":"19","author":"Zhao","year":"2013","journal-title":"CNS Neurosci Therapeut"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2014.03.007_bib32","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.numecd.2005.10.015","article-title":"Endothelial dysfunction in type 2 diabetes mellitus: nutrition, metabolism, and cardiovascular diseases","volume":"16","author":"Avogaro","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jcyt.2014.03.007_bib33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc09-1999","article-title":"Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcyt.2014.03.007_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1475-2840-10-113","article-title":"Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus","volume":"10","author":"Yue","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcyt.2014.03.007_bib35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI29710","article-title":"Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha","volume":"117","author":"Gallagher","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcyt.2014.03.007_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/SLA.0b013e31826a9064","article-title":"A\u00a0novel autologous cell-based therapy to promote diabetic wound healing","volume":"256","author":"Castilla","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcyt.2014.03.007_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3892\/ijmm.2012.1200","article-title":"Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival","volume":"31","author":"Huang","year":"2013","journal-title":"Int J Mol Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:20:21Z","timestamp":1761430821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324914005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1465324914005477"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.03.007","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}